Pancreatic adenocarcinoma Trials in San Antonio, United States
Conditions / Pancreatic adenocarcinoma / San Antonio, United States
Pancreatic adenocarcinoma is a medical condition with active clinical research programs worldwide.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05208762 | A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT04060342 | GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma | TERMINATED | PHASE1 |
| NCT06399757 | A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT01013649 | Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery | COMPLETED | PHASE3 |
| NCT07090499 | A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT05059444 | ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation | RECRUITING | — |
| NCT07349537 | Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors | RECRUITING | PHASE1 |
| NCT05245500 | Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion | RECRUITING | PHASE1 |
| NCT02562716 | S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | COMPLETED | PHASE2 |
| NCT05737706 | Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation | TERMINATED | PHASE1 |